The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity
Overexpression or mutation of α-Synuclein is associated with protein aggregation and interferes with a number of cellular processes, including mitochondrial integrity and function. We used a whole-genome screen in the fruit fly Drosophila melanogaster to search for novel genetic modifiers of human [A53T]α-Synuclein–induced neurotoxicity. Decreased expression of the mitochondrial chaperone protein tumor necrosis factor receptor associated protein-1 (TRAP1) was found to enhance age-dependent loss of fly head dopamine (DA) and DA neuron number resulting from [A53T]α-Synuclein expression. In addition, decreased TRAP1 expression in [A53T]α-Synuclein–expressing flies resulted in enhanced loss of climbing ability and sensitivity to oxidative stress. Overexpression of human TRAP1 was able to rescue these phenotypes. Similarly, human TRAP1 overexpression in rat primary cortical neurons rescued [A53T]α-Synuclein–induced sensitivity to rotenone treatment. In human (non)neuronal cell lines, small interfering RNA directed against TRAP1 enhanced [A53T]α-Synuclein–induced sensitivity to oxidative stress treatment. [A53T]α-Synuclein directly interfered with mitochondrial function, as its expression reduced Complex I activity in HEK293 cells. These effects were blocked by TRAP1 overexpression. Moreover, TRAP1 was able to prevent alteration in mitochondrial morphology caused by [A53T]α-Synuclein overexpression in human SH-SY5Y cells. These results indicate that [A53T]α-Synuclein toxicity is intimately connected to mitochondrial dysfunction and that toxicity reduction in fly and rat primary neurons and human cell lines can be achieved using overexpression of the mitochondrial chaperone TRAP1. Interestingly, TRAP1 has previously been shown to be phosphorylated by the serine/threonine kinase PINK1, thus providing a potential link of PINK1 via TRAP1 to α-Synuclein.
Vyšlo v časopise:
The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity. PLoS Genet 8(2): e32767. doi:10.1371/journal.pgen.1002488
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002488
Souhrn
Overexpression or mutation of α-Synuclein is associated with protein aggregation and interferes with a number of cellular processes, including mitochondrial integrity and function. We used a whole-genome screen in the fruit fly Drosophila melanogaster to search for novel genetic modifiers of human [A53T]α-Synuclein–induced neurotoxicity. Decreased expression of the mitochondrial chaperone protein tumor necrosis factor receptor associated protein-1 (TRAP1) was found to enhance age-dependent loss of fly head dopamine (DA) and DA neuron number resulting from [A53T]α-Synuclein expression. In addition, decreased TRAP1 expression in [A53T]α-Synuclein–expressing flies resulted in enhanced loss of climbing ability and sensitivity to oxidative stress. Overexpression of human TRAP1 was able to rescue these phenotypes. Similarly, human TRAP1 overexpression in rat primary cortical neurons rescued [A53T]α-Synuclein–induced sensitivity to rotenone treatment. In human (non)neuronal cell lines, small interfering RNA directed against TRAP1 enhanced [A53T]α-Synuclein–induced sensitivity to oxidative stress treatment. [A53T]α-Synuclein directly interfered with mitochondrial function, as its expression reduced Complex I activity in HEK293 cells. These effects were blocked by TRAP1 overexpression. Moreover, TRAP1 was able to prevent alteration in mitochondrial morphology caused by [A53T]α-Synuclein overexpression in human SH-SY5Y cells. These results indicate that [A53T]α-Synuclein toxicity is intimately connected to mitochondrial dysfunction and that toxicity reduction in fly and rat primary neurons and human cell lines can be achieved using overexpression of the mitochondrial chaperone TRAP1. Interestingly, TRAP1 has previously been shown to be phosphorylated by the serine/threonine kinase PINK1, thus providing a potential link of PINK1 via TRAP1 to α-Synuclein.
Zdroje
1. MayeuxR 2003 Epidemiology of neurodegeneration. Annu Rev Neurosci 26 81 104
2. MarsdenCD 1983 Neuromelanin and Parkinson's disease. J Neural Transm Suppl 19 121 141
3. LeeFJLiuF 2008 Genetic factors involved in the pathogenesis of Parkinson's disease. Brain Res Rev 58 354 364
4. KeeneyPMXieJCapaldiRABennettJPJr 2006 Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26 5256 5264
5. SchapiraAHCooperJMDexterDClarkJBJennerP 1990 Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54 823 827
6. MizunoYIkebeSHattoriNNakagawa-HattoriYMochizukiH 1995 Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim Biophys Acta 1271 265 274
7. SemchukKMLoveEJLeeRG 1992 Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42 1328 1335
8. LiouHHTsaiMCChenCJJengJSChangYC 1997 Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48 1583 1588
9. CostelloSCockburnMBronsteinJZhangXRitzB 2009 Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol 169 919 926
10. Wood-KaczmarAGandhiSWoodNW 2006 Understanding the molecular causes of Parkinson's disease. Trends in Molecular Medicine 12 521 528
11. SingletonABFarrerMJohnsonJSingletonAHagueS 2003 alpha-Synuclein locus triplication causes Parkinson's disease. Science 302 841
12. Chartier-HarlinMCKachergusJRoumierCMourouxVDouayX 2004 Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364 1167 1169
13. FarrerMKachergusJFornoLLincolnSWangDS 2004 Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55 174 179
14. FuchsJ 2007 Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 68 916 922
15. SpillantiniMGSchmidtMLLeeVMTrojanowskiJQJakesR 1997 Alpha-synuclein in Lewy bodies. Nature 388 839 840
16. LaksoMVartiainenSMoilanenAMSirvioJThomasJH 2003 Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem 86 165 172
17. SmithWWJiangHPeiZTanakaYMoritaH 2005 Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet 14 3801 3811
18. NorrisEHUryuKLeightSGiassonBITrojanowskiJQ 2007 Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am J Pathol 170 658 666
19. MartinLJPanYPriceACSterlingWCopelandNG 2006 Parkinson's Disease {alpha}-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death. J Neurosci 26 41 50
20. HsuLJSagaraYArroyoARockensteinESiskA 2000 {alpha}-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress. Am J Pathol 157 401 410
21. FeanyMBBenderWW 2000 A Drosophila model of Parkinson's disease. Nature 404 394 398
22. Lo BiancoCRidetJLSchneiderBLDeglonNAebischerP 2002 alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc Natl Acad Sci U S A 99 10813 10818
23. EslamboliARomero-RamosMBurgerCBjorklundTMuzyczkaN 2007 Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain 130 799 815
24. ConwayKALeeSJRochetJCDingTTWilliamsonRE 2000 Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97 571 576
25. VollesMJLansburyJPT 2007 Relationships between the Sequence of [alpha]-Synuclein and its Membrane Affinity, Fibrillization Propensity, and Yeast Toxicity. Journal of Molecular Biology 366 1510 1522
26. CuervoAMStefanisLFredenburgRLansburyPTSulzerD 2004 Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305 1292 1295
27. Martinez-VicenteMTalloczyZKaushikSMasseyACMazzulliJ 2008 Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118 777 788
28. PetrucelliLO'FarrellCLockhartPJBaptistaMKehoeK 2002 Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36 1007 1019
29. StefanisLLarsenKERideoutHJSulzerDGreeneLA 2001 Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21 9549 9560
30. SnyderHMensahKTheislerCLeeJMatouschekA 2003 Aggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function. J Biol Chem 278 11753 11759
31. TanakaYEngelenderSIgarashiSRaoRKWannerT 2001 Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 10 919 926
32. LiWWYangRGuoJCRenHMZhaXL 2007 Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport 18 1543 1546
33. LiuGZhangCYinJLiXChengF 2009 alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci Lett 454 187 192
34. LoebVYakuninESaadaASharonR The Transgenic Overexpression of α-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition. Journal of Biological Chemistry 285 7334 7343
35. PariharMSPariharAFujitaMHashimotoMGhafourifarP 2008 Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci 65 1272 1284
36. PariharMSPariharAFujitaMHashimotoMGhafourifarP 2009 Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. The International Journal of Biochemistry & Cell Biology 41 2015 2024
37. ShavaliSBrown-BorgHMEbadiMPorterJ 2008 Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells. Neurosci Lett 439 125 128
38. DeviLRaghavendranVPrabhuBMAvadhaniNGAnandatheerthavaradaHK 2008 Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283 9089 9100
39. PridgeonJWOlzmannJAChinL-SLiL 2007 PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS Biol 5 e172 doi:10.1371/journal.pbio.0050172
40. MuqitMMFeanyMB 2002 Modelling neurodegenerative diseases in Drosophila: a fruitful approach? Nat Rev Neurosci 3 237 243
41. KarpinarDPBalijaMBKuglerSOpazoFRezaei-GhalehN 2009 Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J 28 3256 3268
42. ChenJShiXPadmanabhanRWangQWuZ 2008 Identification of novel modulators of mitochondrial function by a genome-wide RNAi screen in Drosophila melanogaster. Genome Res 18 123 136
43. DuGLiuXChenXSongMYanY Drosophila Histone Deacetylase 6 Protects Dopaminergic Neurons Against {alpha}-Synuclein Toxicity by Promoting Inclusion Formation. Mol Biol Cell E10-03-0200
44. BilenJBoniniNM 2007 Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet 3 e177 doi:10.1371/journal.pgen.0030177
45. ShulmanJMFeanyMB 2003 Genetic modifiers of tauopathy in Drosophila. Genetics 165 1233 1242
46. HuaGZhangQFanZ 2007 Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J Biol Chem 282 20553 20560
47. ImCNLeeJSZhengYSeoJS 2007 Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates production of reactive oxygen species. J Cell Biochem 100 474 486
48. MasudaYShimaGAiuchiTHorieMHoriK 2004 Involvement of Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) in Apoptosis Induced by Î-Hydroxyisovalerylshikonin. Journal of Biological Chemistry 279 42503 42515
49. XiangFHuangYSShiXHZhangQ Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening. FEBS J 277 1929 1938
50. PanaretouBProdromouCRoeSMO'BrienRLadburyJE 1998 ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J 17 4829 4836
51. KampFExnerNLutzAKWenderNHegermannJ 2010 Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29 3571 3589
52. LeavIPlesciaJGoelHLLiJJiangZ Cytoprotective Mitochondrial Chaperone TRAP-1 As a Novel Molecular Target in Localized and Metastatic Prostate Cancer. Am J Pathol 176 393 401
53. CostantinoEMaddalenaFCaliseSPiscazziATirinoV 2009 TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer letters 279 39 46
54. GesualdiNMChiricoGPirozziGCostantinoELandriscinaM 2007 Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress: The International Journal on the Biology of Stress 10 342 350
55. TakahashiMKanukaHFujiwaraHKoyamaAHasegawaM 2003 Phosphorylation of [alpha]-synuclein characteristic of synucleinopathy lesions is recapitulated in [alpha]-synuclein transgenic Drosophila. Neuroscience Letters 336 155 158
56. BotellaJABayersdorferFSchneuwlyS 2008 Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease. Neurobiol Dis 30 65 73
57. Shaltiel-KaryoRFrenkel-PinterMEgoz-MatiaNFrydman-MaromAShalevDE Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating α-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies. PLoS ONE 5 e13863 doi:10.1371/journal.pone.0013863
58. van HamTJThijssenKLBreitlingRHofstraRMWPlasterkRHA 2008 C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging. PLoS Genetics 4 e1000027 doi:10.1371/journal.pgen.1000027
59. Montesano GesualdiNChiricoGPirozziGCostantinoELandriscinaM 2007 Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress 10 342 350
60. ChoiWSEomDSHanBSKimWKHanBH 2004 Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 279 20451 20460
61. HwangSKimDChoiGAnSWHongYK 2010 Parkin suppresses c-Jun N-terminal kinase-induced cell death via transcriptional regulation in Drosophila. Mol Cells 29 575 580
62. NovikovaLGarrisBLGarrisDRLauYS 2006 Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Neuroscience 140 67 76
63. SinghSKumarSDikshitM 2010 Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide. Redox Rep 15 115 122
64. Abou-SleimanPMMuqitMMWoodNW 2006 Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 7 207 219
65. BüelerH 2009 Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Experimental Neurology 218 235 246
66. ParkerWDJrBoysonSJParksJK 1989 Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26 719 723
67. PatkiGCheYLauYS 2009 Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson's disease. Front Aging Neurosci 1 3
68. SchapiraAHV 2008 Mitochondria in the aetiology and pathogenesis of Parkinson's disease. The Lancet Neurology 7 97 109
69. SongDDShultsCWSiskARockensteinEMasliahE 2004 Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186 158 172
70. VilaMRamonetDPerierC 2008 Mitochondrial alterations in Parkinson's disease: new clues. J Neurochem 107 317 328
71. WinklhoferKFHaassC 2010 Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta 1802 29 44
72. DagdaRKChuCT 2009 Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J Bioenerg Biomembr 41 473 479
73. ExnerNTreskeBPaquetDHolmstromKSchieslingC 2007 Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27 12413 12418
74. KitadaTAsakawaSHattoriNMatsumineHYamamuraY 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 605 608
75. LutzAKExnerNFettMESchleheJSKloosK 2009 Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 284 22938 22951
76. MoraisVAVerstrekenPRoethigASmetJSnellinxA 2009 Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1 99 111
77. SandebringADehvariNPerez-MansoMThomasKJKarpilovskiE 2009 Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling. FEBS J 276 5041 5052
78. SandebringAThomasKJBeilinaAvan der BrugMClelandMM 2009 Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS ONE 4 e5701 doi:10.1371/journal.pone.0005701
79. StraussKMMartinsLMPlun-FavreauHMarxFPKautzmannS 2005 Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 14 2099 2111
80. ValenteEMSalviSIalongoTMarongiuREliaAE 2004 PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 56 336 341
81. VoigtAHerholzDFieselFCKaurKMullerD 2010 TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS ONE 5 e12247 doi:10.1371/journal.pone.0012247
82. AuluckPKChanHYTrojanowskiJQLeeVMBoniniNM 2002 Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295 865 868
83. BayersdorferFVoigtASchneuwlySBotellaJA Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease. Neurobiology of Disease In Press, Corrected Proof
84. LivakKJSchmittgenTD 2001 Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-[Delta][Delta]CT Method. Methods 25 402 408
85. ReichASperingCGertzKHarmsCGerhardtE 2011 Fas/CD95 Regulatory Protein Faim2 Is Neuroprotective after Transient Brain Ischemia. J Neurosci 31 225 233
86. GeggMECooperJMSchapiraAHVTaanmanJ-W 2009 Silencing of PINK1 Expression Affects Mitochondrial DNA and Oxidative Phosphorylation in DOPAMINERGIC Cells. PLoS ONE 4 e4756 doi:10.1371/journal.pone.0004756
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 2
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Gene Expression and Stress Response Mediated by the Epigenetic Regulation of a Transposable Element Small RNA
- Contrasting Properties of Gene-Specific Regulatory, Coding, and Copy Number Mutations in : Frequency, Effects, and Dominance
- Homeobox Genes Critically Regulate Embryo Implantation by Controlling Paracrine Signaling between Uterine Stroma and Epithelium
- Nondisjunction of a Single Chromosome Leads to Breakage and Activation of DNA Damage Checkpoint in G2